scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037187033 |
P356 | DOI | 10.1186/1471-2199-11-93 |
P8608 | Fatcat ID | release_radyjydlzvhvjmiqtwvjqgk7gm |
P932 | PMC publication ID | 3047298 |
P698 | PubMed publication ID | 21134262 |
P5875 | ResearchGate publication ID | 49660811 |
P50 | author | Julian Paton | Q43084716 |
P2093 | author name string | Haibo Xu | |
Sergey Kasparov | |||
Beihui Liu | |||
P2860 | cites work | Differences in transductional tropism of adenoviral and lentiviral vectors in the rat brainstem. | Q50781742 |
Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. | Q51192662 | ||
Reduced neuronal nitric oxide synthase is involved in ischemia-induced hippocampal neurogenesis by up-regulating inducible nitric oxide synthase expression | Q81248178 | ||
Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo | Q95806231 | ||
Tuning silence: conditional systems for RNA interference | Q36575390 | ||
MicroRNAs in disease and potential therapeutic applications | Q36945531 | ||
Small silencing RNAs: state-of-the-art | Q37475724 | ||
RNAi therapeutics for CNS disorders | Q37716069 | ||
Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter | Q40049737 | ||
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins | Q40589574 | ||
CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression | Q40606300 | ||
Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo | Q40682749 | ||
Lentiviral vectors: regulated gene expression | Q40863126 | ||
Transgenic neuronal nitric oxide synthase expression induces axotomy-like changes in adult motoneurons | Q42957375 | ||
Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors | Q44287931 | ||
A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver | Q44490527 | ||
Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression | Q45161156 | ||
Subcellular localization of neuronal nitric oxide synthase in the rat nucleus of the solitary tract in relation to vagal afferent inputs. | Q47993471 | ||
Nitric oxide system is involved in hypobaric hypoxia-induced oxidative stress in rat brain | Q48625280 | ||
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation | Q21194851 | ||
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms | Q24680714 | ||
A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells | Q28207586 | ||
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors | Q28275174 | ||
Strategies for silencing human disease using RNA interference | Q28288535 | ||
Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem | Q28575345 | ||
Localization of vesicular glutamate transporters and neuronal nitric oxide synthase in rat nucleus tractus solitarii | Q33195811 | ||
Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo | Q33712990 | ||
Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages | Q33770336 | ||
A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells | Q33938488 | ||
Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain | Q34233867 | ||
siRNAs: applications in functional genomics and potential as therapeutics | Q34310668 | ||
miRNAs on the move: miRNA biogenesis and the RNAi machinery | Q34320973 | ||
Gene silencing using micro-RNA designed hairpins | Q34364532 | ||
Cell-type-specific signatures of microRNAs on target mRNA expression | Q34479693 | ||
RNAi therapeutics: principles, prospects and challenges | Q34621268 | ||
RNAi-based therapeutics-current status, challenges and prospects | Q34659612 | ||
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression | Q35013068 | ||
Tissue-specific and reversible RNA interference in transgenic mice | Q36129232 | ||
MicroRNA expression in the adult mouse central nervous system | Q36470289 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 93 | |
P577 | publication date | 2010-12-06 | |
P1433 | published in | BMC Molecular Biology | Q15760954 |
P1476 | title | Cell- and region-specific miR30-based gene knock-down with temporal control in the rat brain | |
P478 | volume | 11 |
Q37978318 | Gene regulation systems for gene therapy applications in the central nervous system. |
Q41643528 | Gene transfer engineering for astrocyte-specific silencing in the CNS. |
Q37967602 | Genetic approaches to study glial cells in the rodent brain. |
Q57916488 | Glio- and neuro-protection by prosaposin is mediated by orphan G-protein coupled receptors GPR37L1 and GPR37 |
Q46168221 | Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats |